These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7608748)

  • 1. Conformational studies on the four stereoisomers of the novel anticholinergic 4-(dimethylamino)-2-phenyl-2-(2-pyridyl)pentanamide.
    Oyasu H; Nakanishi I; Tanaka A; Murano K; Matsuo M
    J Comput Aided Mol Des; 1995 Apr; 9(2):171-80. PubMed ID: 7608748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and anticholinergic activity of the four stereoisomers of 4-(dimethylamino)-2-phenyl-2-(2-pyridyl)pentanamide.
    Oyasu H; Nagano M; Akahane A; Tomoi M; Tada T; Matsuo M
    J Med Chem; 1994 Apr; 37(9):1378-81. PubMed ID: 8176715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantioselectivity of muscarinic antagonists. Isomeric 2-cyclohexyl-2-phenyl-5-[(dimethylamino)methyl]-1,3-oxathiolane 3-oxide methiodides.
    Romanelli MN; Gualtieri F; Angeli P; Picchio MT
    J Med Chem; 1989 Oct; 32(10):2269-73. PubMed ID: 2795598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoisomers of N-substituted soft anticholinergics and their zwitterionic metabolite based on glycopyrrolate--syntheses and pharmacological evaluations.
    Wu WM; Wu J; Mori N; Buchwald P; Bodor N
    Pharmazie; 2008 Mar; 63(3):200-9. PubMed ID: 18444508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
    Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
    J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates.
    Iqbal N; Akula MR; Vo D; Matowe WC; McEwen CA; Wolowyk MW; Knaus EE
    J Med Chem; 1998 May; 41(11):1827-37. PubMed ID: 9599233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative anticholinergic potencies of R- and S- disopyramide in longitudinal muscle strips from guinea pig ileum.
    Giacomini KM; Cox BM; Blaschke TF
    Life Sci; 1980 Sep; 27(13):1191-7. PubMed ID: 7421405
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative structure-activity relationships of benzamide derivatives for anti-leukotriene activities.
    Goto S; Guo Z; Futatsuishi Y; Hori H; Taira Z; Terada H
    J Med Chem; 1992 Jun; 35(13):2440-5. PubMed ID: 1619618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic evaluations of the zwitterionic metabolite of a new series of N-substituted soft anticholinergics.
    Wu WM; Buchwald P; Mori N; Ji F; Wu J; Bodor N
    Pharm Res; 2005 Dec; 22(12):2035-44. PubMed ID: 16170596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI; Omnaas JR; Lomize A; Heyl DL; Nordan I; Mousigian C; Davis P; Porreca F
    J Med Chem; 1994 Dec; 37(25):4384-91. PubMed ID: 7996550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, structure, and pharmacological evaluation of the stereoisomers of furnidipine.
    Alajarin R; Vaquero JJ; Alvarez-Builla J; Pastor M; Sunkel C; Fau de Casa-Juana M; Priego J; Statkow PR; Sanz-Aparicio J; Fonseca I
    J Med Chem; 1995 Jul; 38(15):2830-41. PubMed ID: 7636844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformationally restricted analogs of histamine H1 receptor antagonists: trans and cis-1-benzyl-3-dimethylamino-6-phenylpiperidine.
    Ahmed AE; Hanna PE; Grund VR
    J Med Chem; 1976 Jan; 19(1):117-22. PubMed ID: 1535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and biological effects of pure stereoisomeric novel soft anticholinergics.
    Tóth-Sarudy E; Tóth G; Pallagi I; Seres G; Vitális B; Tapfer M; Perczel V; Kurucz I; Bodor N; Zubovics Z
    Pharmazie; 2006 Feb; 61(2):90-6. PubMed ID: 16526553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine.
    Triggle AM; Shefter E; Triggle DJ
    J Med Chem; 1980 Dec; 23(12):1442-5. PubMed ID: 6256552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and anticholinergic properties of the enantiomers of 4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide, the mono-N-dealkylated metabolite of disopyramide.
    Nelson WL; Sneed CK; Giacomini KM; Giacomini JC; Stauss J; Blaschke TF; Cox BM
    J Med Chem; 1981 May; 24(5):614-7. PubMed ID: 7241519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new structural motif for mu-opioid antagonists.
    Van den Eynde I; Laus G; Schiller PW; Kosson P; Chung NN; Lipkowski AW; Tourwé D
    J Med Chem; 2005 May; 48(10):3644-8. PubMed ID: 15887972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantioselectivity of muscarinic antagonists. Isomeric 2-cyclohexyl-2-phenyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodides.
    Romanelli MN; Gualtieri F; Valle G; Brasili L; Angeli P
    J Med Chem; 1988 Sep; 31(9):1703-8. PubMed ID: 3411599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N(alpha)-imidazolylalkyl and pyridylalkyl derivatives of histaprodifen: synthesis and in vitro evaluation of highly potent histamine H(1)-receptor agonists.
    Menghin S; Pertz HH; Kramer K; Seifert R; Schunack W; Elz S
    J Med Chem; 2003 Dec; 46(25):5458-70. PubMed ID: 14640554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of three-dimensional structure of muscarinic antagonists to antimuscarinic activity: structure of thiodeacylaprophen hydrochloride.
    Karle JM; Karle IL; Gordon RK; Chiang PK
    Acta Crystallogr B; 1992 Apr; 48 ( Pt 2)():208-13. PubMed ID: 1515109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modification of anticholinergics as probes for muscarinic receptors. 3. Conformationally restricted analogues of benactyzine.
    Flavin MT; Lu MC; Thompson EB; Bhargava HN
    J Med Chem; 1987 Feb; 30(2):278-85. PubMed ID: 3806613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.